Litcius/Paper detail

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies

Dulce M. Barrios, Gregory S. Phillips, Amaris Geisler, Sabrina Trelles, Alina Markova, Sarah Noor, Elizabeth Quigley, Helen Haliasos, Andrea P. Moy, Alison M. Schram, J. Bromberg, Samuel A. Funt, Martin H. Voss, Alexander Drilon, Matthew D. Hellmann, Elizabeth Comen, Saisindhu Narala, Anisha B. Patel, Megan Wetzel, Jae Yeon Jung, Donald Y.M. Leung, Mario E. Lacouture

2021Annals of Oncology51 citationsDOIOpen Access PDF

Topics & Concepts

OmalizumabMedicineAdverse effectInternal medicineImmunoglobulin EDermatologyAnaphylaxisGastroenterologyAllergyImmunologyAntibodyCancer Immunotherapy and BiomarkersDermatology and Skin DiseasesUrticaria and Related Conditions
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies | Litcius